| Slide Lecture Programs |
| Postintervention Continuum of Care: Focus on Lipids |
|
November 1, 1999
|
| I: |
Achievements and challenges in medical interventional approaches" width="220" height="147" border="0">
Postintervention continuum of care: Focus on lipids
|
|
 |
|
 |
|
|
 |
3 |
 |
| |

Leading causes of death for all males and females
|
|
 |
|
 |
|
 |
4 |
 |
| |

Percentage breakdown of deaths from cardiovascular disease
|
|
 |
|
 |
|
 |
5 |
 |
| |

Adjusted rates of in-hospital outcomes after PCI by year of procedure
|
|
 |
|
 |
|
 |
6 |
 |
| |

Prevention of stent thrombosis: Overview of key trials
|
|
 |
|
 |
|
 |
7 |
 |
| |

Coronary angioplasty vs CABG: Overall survival and survival free from Q-wave MI
|
|
 |
|
 |
|
 |
8 |
 |
| |

Coronary angioplasty vs antianginal medical therapy: Greater improvement of angina
|
|
 |
|
 |
|
|
|
 |
10 |
 |
| |

Natural history of atherosclerosis and postintervention: Important differences
|
|
 |
|
 |
|
 |
11 |
 |
| |

Pathobiologic responses to intervention
|
|
 |
|
 |
|
 |
12 |
 |
| |

Postintervention: Two different pathobiologies
|
|
 |
|
 |
|
 |
13 |
 |
| |

Management of atherosclerosis and postintervention: Important differences
|
|
 |
|
 |
|
|